onkommon.com
Other cancers · free patient guide
Cancer of unknown primary
CUP, cancer found without an identified site of origin
Cancer of unknown primary pathway · Coming soon
What it is
Cancer of unknown primary means disease has been found, usually in a node, the liver or the bones, without an identified site of origin. In some cases the primary is simply too small to see; in others it has regressed.
The important shift is that treatment increasingly follows the tumour's biology rather than the search for its address.
Being told there is cancer but nobody knows where it started is among the most distressing situations in oncology, and the conventional response, a sequential hunt through one scan after another, wastes the time that matters most.
Warning signs worth acting on
- An enlarged node, or a mass found on imaging, with no obvious source
- A biopsy report describing metastatic cancer without a stated primary site
- Being told 'we need more scans' repeatedly over several weeks without a plan
How it is diagnosed
- Thorough pathology review with an extended immunohistochemistry panel, this identifies the origin in many cases
- Comprehensive genomic profiling as a first-line strategy rather than a last resort
- Targeted imaging based on what the pathology suggests, rather than scanning everything
- Tissue-of-origin reasoning at the tumour board
This is the disease where comprehensive profiling earns its cost most clearly. It can identify the likely origin, find actionable alterations, and in doing so replace a sequence of investigations that would have taken weeks.
Is it inherited?
Depends on what the profiling suggests. Germline testing is considered where the findings point to a hereditary syndrome.
Genetic counselling & family risk →
Prevention & early detection
Not applicable. What is applicable is insisting on proper pathology review rather than an open-ended sequence of scans.
Treatment options
What may form part of a plan
Which of these apply to you depends on your stage, your pathology, your other health and what you want from treatment. That decision belongs at a tumour board, not on a website.
Chemotherapy
Drug treatment that acts on rapidly dividing cells throughout the body.
Targeted therapy
Medicines matched to a specific alteration found in your tumour.
Immunotherapy
Treatment that works on the immune system rather than directly on the tumour.
Radiotherapy
Targeted radiation to a defined area, planned in millimetres.
Clinical trials
Most Indian patients never learn a trial exists, because nobody is looking.
Conservative management & active surveillance
Sometimes the right decision is to watch carefully and treat nothing yet.
At KPCIRC
The pathway for this disease
- Comprehensive genomic profiling first, rather than sequential site hunting
- Extended immunohistochemistry and independent pathology review
- Complex & Rare Case Board review with invited sub-specialists
- Trial and expanded-access searching as part of the workup
- A clear timeline, so the search does not become indefinite
Support that matters most here
Take this with you
Questions to ask your own doctor
These work wherever you are treated. Print the page or take a photograph of this list.
- Has the pathology had a full immunohistochemistry panel?
- Has comprehensive genomic profiling been done, and what did it show?
- How long will we keep searching before we treat?
- Is there a trial for cancers of unknown primary?
This page is not an emergency service. Severe breathlessness, chest pain, uncontrolled bleeding, a high fever during chemotherapy, or a sudden change in alertness means going to your nearest emergency department now, not reading further.